Publications by authors named "J-M Michot"

Claim this Profile
I
Infectious Complications in Patients Treated With T-cell Engagers as Cancer Immunotherapies, a Descriptive Study From the REISAMIC Registry.
Thomas Hueso, Justin Cagnat, Kaïssa Ouali, Mathilde Haberstich, Benoît Henry, Jean-Marie Michot

Clin Infect Dis· December 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
Necrotizing and Nonnecrotizing Granulomatous Reactions in Patients With Cancer Treated With Immune Checkpoint Inhibitors: A Systematic Literature Review.
Elizabeth Y Wang, Genna Braverman, Nilasha Ghosh, Deanna P Jannat-Khah, Karmela K Chan, Jean-Marie Michot

J Rheumatol· December 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
Notch pathway inhibition with crenigacestat (LY3039478) in a phase I first-in-human clinical trial for patients with relapsed or refractory non-Hodgkin lymphoma and B-cell chronic lymphocytic leukemia.
Jean-Marie Michot, Zsofia Balogh, Jennifer R Brown, Vincent Ribrag, Antoine Hollebecque

Ther Adv Drug Saf· July 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
O
Odronextamab monotherapy in R/R DLBCL after progression with CAR T-cell therapy: primary analysis of the ELM-1 study.
Max S Topp, Matthew Matasar, John N Allan, Stephen M Ansell, Jeffrey A Barnes, Jean-Marie Michot

Blood· April 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
[
[Toxicity of targeted therapies and immunotherapy with checkpointinhibitors in Hodgkin lymphoma].
Jean-Marie Michot, Julien Lazarovici

Rev Prat· June 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
B
BET inhibitor trotabresib in heavily pretreated patients with solid tumors and diffuse large B-cell lymphomas.
Victor Moreno, Maria Vieito, Juan Manuel Sepulveda, Vladimir Galvao, Tatiana Hernández-Guerrero, Jean-Marie Michot

Nat Commun· March 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Seroconversion rate after vaccination against COVID-19 in patients with cancer-a systematic review.
C Corti, G Antonarelli, F Scotté, J P Spano, J Barrière, J M Michot

Ann Oncol· February 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Immune checkpoint inhibitor-associated sarcoidosis: A usually benign disease that does not require immunotherapy discontinuation.
Noémie Chanson, Manuel Ramos-Casals, Xerxes Pundole, Karijn Suijkerbuijk, Milton José de Barros E Silva, Jean-Marie Michot

Eur J Cancer· November 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Absence of significant clinical benefit for a systematic routine creatine phosphokinase measurement in asymptomatic patients treated with anti-programmed death protein (ligand) 1 immune checkpoint inhibitor to screen cardiac or neuromuscular immune-related toxicities.
Samia Hajem, Stéphane Ederhy, Stéphane Champiat, Frédéric Troalen, Alexis Nolin-Lapalme, Jean-Marie Michot

Eur J Cancer· November 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The determinants of very severe immune-related adverse events associated with immune checkpoint inhibitors: A prospective study of the French REISAMIC registry.
Valentine Ruste, Vincent Goldschmidt, Ariane Laparra, Sabine Messayke, Francois-Xavier Danlos, Jean-Marie Michot

Eur J Cancer· November 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
O
Outcomes of patients with cancer and sarcoid-like granulomatosis associated with immune checkpoint inhibitors: A case-control study.
Charlotte Cabanié, Samy Ammari, Sophie Hans, Cedric Pobel, Ariane Laparra, Jean-Marie Michot

Eur J Cancer· October 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Sustained cancer clinical trial activity in a French hospital during the first wave of the COVID-19 pandemic.
Arnaud Bayle, Capucine Baldini, Patricia Martin-Romano, Jean-Marie Michot, Stéphane Champiat

Cancer Cell· August 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Longitudinally Extensive Myelitis Associated With Immune Checkpoint Inhibitors.
Alberto Picca, Giulia Berzero, Kevin Bihan, Vincent Jachiet, Edouard Januel, Jean-Marie Michot

Neurol Neuroimmunol Neuroinflamm· May 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Long-term impact of immunotherapy on quality of life of surviving patients: A multi-dimensional descriptive clinical study.
Paul-Albert Domnariu, Nicolas Noel, Isabelle Hardy-Leger, Jean-Marie Michot, Olivier Lambotte

Eur J Cancer· May 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
[
[Management of adverse events associated with cancer immunotherapy].
Ariane Laparra, Stéphane Champiat, Jean-Marie Michot, Olivier Lambotte

Rev Prat· April 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
[
[Specific management of the most common toxicities of anti-PD1].
Ariane Laparra, Stéphane Champiat, Jean-Marie Michot, Olivier Lambotte

Rev Prat· April 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
K
KEYNOTE-013 4-year follow-up of pembrolizumab in classical Hodgkin lymphoma after brentuximab vedotin failure.
Philippe Armand, John Kuruvilla, Jean-Marie Michot, Vincent Ribrag, Pier Luigi Zinzani

Blood Adv· June 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
[
[Management of adverse events associated with cancer immunotherapy].
Stéphane Champiat, Jean-Marie Michot, Olivier Lambotte

Rev Prat· January 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Antiviral Treatment of HCV-Infected Patients with B-Cell Non-Hodgkin Lymphoma: ANRS HC-13 Lympho-C Study.
Laurent Alric, Caroline Besson, Nathanael Lapidus, Juliette Jeannel, Jean-Marie Michot

PLoS One· May 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Cellular accumulation and activity of quinolones in ciprofloxacin-resistant J774 macrophages.
Jean-Michel Michot, Marie F Heremans, Nancy E Caceres, Marie-Paule Mingeot-Leclercq, Paul M Tulkens

Antimicrob Agents Chemother· May 2006

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Influence of efflux transporters on the accumulation and efflux of four quinolones (ciprofloxacin, levofloxacin, garenoxacin, and moxifloxacin) in J774 macrophages.
Jean-Michel Michot, Cristina Seral, Françoise Van Bambeke, Marie-Paule Mingeot-Leclercq, Paul M Tulkens

Antimicrob Agents Chemother· June 2005

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis